Schedule 13G ownership disclosure
NLS PHARMACEUTICS LTD
Security class unavailable · CUSIP: H57830103
Event date: 2022-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 3.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-23-010726
- Form type
- SC 13G
- Filer
- NewcelX Ltd.
- CIK
- CIK 1783036
- Filed
- Feb 13, 2023
- Reporting period
- Dec 31, 2022
- Description
- Schedule 13G beneficial ownership